Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Institut Bergonié
Elevation Oncology
Sarcoma Oncology Research Center, LLC
Ann & Robert H Lurie Children's Hospital of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Virginia
Pfizer
Albert Einstein College of Medicine
pharmaand GmbH
Hoffmann-La Roche
City of Hope Medical Center
Nektar Therapeutics
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
National Institutes of Health Clinical Center (CC)
Pfizer
University of South Florida
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Virginia Commonwealth University
Masonic Cancer Center, University of Minnesota
Medical College of Wisconsin
National Institutes of Health Clinical Center (CC)
Columbia University
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of South Florida
National Cancer Institute (NCI)
GE Healthcare
INSYS Therapeutics Inc
Pfizer